Sayka Khan, Tanisha TabassumSrishti, Sanjida Ahmed2023-01-162023-01-1620212021-12ID: 17346004http://hdl.handle.net/10361/17731Cataloged from PDF version of thesis.Includes bibliographical references (pages 54-68).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.CRISPR/Cas system is a novel and highly adaptable technique that has evolved as a potential therapeutic and molecular diagnostic tool. As a promising novel antiviral approach, CRISPR technology is utilized in the degradation of human pathogenic viruses by either targeting the specific viral DNA directly or interfering with the spontaneous generation of host cellular components required for viral replication. This review focuses on the advancement in treatment and diagnosis of several infectious viral diseases such as Human immunodeficiency virus, Hepatitis B virus, Herpes simplex virus, SARS-CoV-2 and Human Papillomavirus through the application of revolutionary CRISPR/Cas system. It also discusses about various types of vectors that are utilized in the CRISPR/Cas system delivery. Moreover, it points out the prospects and challenges associated with the CRISPR/Cas system.68 Pagesen-USBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.CRISPR-CasGenome editingAntiviral toolVectorsSHERLOCKGenetic engineeringGene editing--Technological innovationsThesis